Literature DB >> 27579131

Moyamoya disease in pregnancy: maintenance of maternal blood pressure.

Helen L Barrett1, Karin Lust2, Narelle Fagermo2, Leonie K Callaway2, Lee Minuzzo3.   

Abstract

Moyamoya disease is a rare cerebrovascular occlusive disorder characterized by stenosis in the circle of Willis with the development of a compensatory circulation. It has been associated with significant morbidity in pregnancy including intracranial haemorrhage, ischaemic stroke and epilepsy. We present the case of a 26-year-old woman with a previous diagnosis of moyamoya vasculopathy with bilateral superficial temporal to middle cerebral artery bypass grafting. During the second trimester, she developed significant neurological symptoms related to postural hypotension in the presence of a stenosis of the right-sided graft. The hypotension was treated with fludrocortisone therapy with improvement in blood pressure and symptoms. Moyamoya vasculopathy poses unique challenges to obstetric care. This is the first report of use of fludrocortisone for maintenance of blood pressure during pregnancy in this condition.

Entities:  

Keywords:  cerebral artery bypass grafting; fludrocortisone; hypotension; moyamoya disease; pregnancy

Year:  2011        PMID: 27579131      PMCID: PMC4989678          DOI: 10.1258/om.2011.110046

Source DB:  PubMed          Journal:  Obstet Med        ISSN: 1753-495X


  14 in total

1.  Linkage analysis of moyamoya disease on chromosome 6.

Authors:  T K Inoue; K Ikezaki; T Sasazuki; T Matsushima; M Fukui
Journal:  J Child Neurol       Date:  2000-03       Impact factor: 1.987

2.  Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan.

Authors:  M Fukui
Journal:  Clin Neurol Neurosurg       Date:  1997-10       Impact factor: 1.876

3.  Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain.

Authors:  J Suzuki; A Takaku
Journal:  Arch Neurol       Date:  1969-03

4.  Cortical blood flow response to hypercapnia during anaesthesia in Moyamoya disease.

Authors:  K Kurehara; H Ohnishi; H Touho; H Furuya; T Okuda
Journal:  Can J Anaesth       Date:  1993-08       Impact factor: 5.063

5.  Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25.

Authors:  T Yamauchi; M Tada; K Houkin; T Tanaka; Y Nakamura; S Kuroda; H Abe; T Inoue; K Ikezaki; T Matsushima; M Fukui
Journal:  Stroke       Date:  2000-04       Impact factor: 7.914

6.  Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26.

Authors:  H Ikeda; T Sasaki; T Yoshimoto; M Fukui; T Arinami
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

7.  Autosomal dominant moyamoya disease maps to chromosome 17q25.3.

Authors:  Y Mineharu; W Liu; K Inoue; N Matsuura; S Inoue; K Takenaka; H Ikeda; K Houkin; Y Takagi; K Kikuta; K Nozaki; N Hashimoto; A Koizumi
Journal:  Neurology       Date:  2008-05-07       Impact factor: 9.910

8.  Cerebral haemodynamics in pregnancy and pre-eclampsia as assessed by transcranial Doppler ultrasonography.

Authors:  R W Sherman; R A Bowie; M M E Henfrey; R P Mahajan; D Bogod
Journal:  Br J Anaesth       Date:  2002-11       Impact factor: 9.166

9.  Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey.

Authors:  Shinichi Kuriyama; Yasuko Kusaka; Miki Fujimura; Kenji Wakai; Akiko Tamakoshi; Shuji Hashimoto; Ichiro Tsuji; Yutaka Inaba; Takashi Yoshimoto
Journal:  Stroke       Date:  2007-11-29       Impact factor: 7.914

10.  Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article.

Authors:  Raphael Guzman; Marco Lee; Achal Achrol; Teresa Bell-Stephens; Michael Kelly; Huy M Do; Michael P Marks; Gary K Steinberg
Journal:  J Neurosurg       Date:  2009-11       Impact factor: 5.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.